NYSE: CATX - Perspective Therapeutics, Inc.

半年間の収益性: +737.33%
セクタ: Healthcare

プロモーションスケジュール Perspective Therapeutics, Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc.

さらに詳しく
and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

Цена ао 1.24
Выручка 0.0073
EBITDA -0.0053
Число акций ао 0.1421 млрд
P/S 3.76
P/BV 3.58
EV/EBITDA -4.18
ISIN US46489V1044
Сайт https://www.perspectivetherapeutics.com
Валюта usd
IPO date 2005-11-10
Sector Health Care
Industry Health Care Equipment & Supplies
Валюта отчета usd
1日あたりの価格変動: 0% (12.56)
週ごとの価格変動: -4.12% (13.1)
月ごとの料金変更: -16.82% (15.1)
3ヶ月間の価格変動: +5.63% (11.89)
半年間の価格変動: +737.33% (1.5)
年間の価格変動: +4 086.67% (0.3)
3年間の価格推移: +2 028.81% (0.59)
5年間の価格推移: +3 951.61% (0.31)
年初からの価格変動: +4 730.77% (0.26)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 133.02 1
P/BV 17.29 1
P/E 0 0
EV/EBITDA -62.27 0
合計: 0.875

効率

名前 意味 学年
ROA, % -25.25 0
ROE, % -26.85 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.1163 10
合計: 9.6

成長の衝動

名前 意味 学年
収益性 Revenue, % -2.68 0
収益性 Ebitda, % 179.96 10
収益性 EPS, % 42.79 6
合計: 7.2
さらに詳しく

機関 音量 共有, %
Vanguard Group Inc 13213750 2.25
Baker Brothers Advisors, LLC 7639703 1.3
Blackrock Inc. 4538389 0.77
Geode Capital Management, LLC 2516649 0.43
Ghost Tree Capital, LLC 1600000 0.27
Osterweis Capital Management, Inc. 1582100 0.27
HighTower Advisors, LLC 1332238 0.23
Perkins Capital Management, Inc. 700000 0.12
State Street Corporation 671524 0.11
Taylor & Morgan Wealth Management, LLC 625000 0.11

ETF 共有, % 年間の利益率, % 配当金, %
iShares Morningstar Small-Cap ETF 0.01351 30.095066471445 1.60498
iShares Morningstar Small-Cap Growth ETF 0.02697 33.628071953382 0.72598
iShares Russell 2000 Growth ETF 0.04295 38.042556988 0.6026
iShares Russell 3000 ETF 0.00132 31.230028873917 1.43482
iShares Morningstar Small-Cap ETF 0.01351 391.25300933451 1.60498
iShares Morningstar Small-Cap Growth ETF 0.02697 682.83677107207 0.72598



スーパーバイザー 役職 支払い 生年
Mr. Johan M. Spoor CEO & Director 855.78k 1972 (52 年)
Mr. Jonathan R. Hunt CFO and Principal Financial & Accounting Officer 944.35k 1967 (57 年)
Mr. Shane Cobb Executive Vice President of Operations N/A
Dr. Michael K. Schultz Ph.D. Chief Science Officer N/A
Mr. Andrew Bright Executive Vice President of Brachytherapy N/A
Dr. Markus Puhlmann M.B.A., M.D. Chief Medical Officer 633.14k 1966 (58 年)
Mr. Amos Hedt BA, PGradDip Chief Business Strategy Officer N/A
Dr. Frances L. Johnson M.D. Chief Innovation Officer N/A
Mr. David Hauser Ph.D. Senior Vice President of Clinical Operations N/A
Steve Keefe Senior Vice President of Clinical Development

住所: United States, Richland. WA, 350 Hills Street - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.perspectivetherapeutics.com